Antibody Therapeutics Market to Surge from $293.3B in 2023 to $728.8B by 2030
The Antibody Therapeutics Market has been on a steady rise and shows no signs of slowing down. In 2023, the market was valued at a staggering USD 293.3 billion and is projected to surpass USD 728.8 billion by 2030. With a Compound Annual Growth Rate (CAGR) of 13.9% from 2024 to 2030, the market is positioned to play a pivotal role in revolutionizing healthcare. This article dives deep into the driving factors behind this growth, key players in the market, and the potential challenges it may face. What Are Antibody Therapeutics? Antibody therapeutics are treatments that involve the use of antibodies to target specific cells or proteins in the body. These antibodies, which are naturally produced by the immune system, can be engineered to treat various diseases, including cancer, autoimmune disorders, and infectious diseases. The beauty of antibody therapeutics lies in their precision—unlike traditional therapies, they target specific cells, minimizing damage to healthy tissue